Biopharmaceutical company UCB names Gwinnett County site of 1st U.S. biologics facility
Originally published in CBS News Atlanta.
Global biopharmaceutical company UCB, Inc. has named Gwinnett County the site of its first pharmaceutical biologics manufacturing facility in the United States.
The Belgian drugmaker and Georgia Gov. Brian Kemp announced the plan for the facility on Tuesday.
Officials say UCB plans to invest $2 billion in Georgia as part of the work at the new site, which will be located on the Rowen Foundation’s 2,000-acre science and learning campus near Dacula.
“When we met with UCB leadership earlier this year in Belgium, we discussed how the Peach State would be the right partner for their visionary plans in the U.S. that will benefit both patients and hardworking Georgians,” Kemp said. “UCB’s announcement is also a significant milestone for our life sciences industry, representing one of the largest investments in state history and establishing both the Rowen facility and Georgia as a true hub of innovation in this field.”
The new facility would create 330 permanent jobs in biologics manufacturing and more than 1,000 construction jobs. UCB estimated it would generate an estimated $5 billion in economic impact for the area.
A visit to the ‘Campus UCB’ gene therapy facility of bio-pharmaceutical company UCB in Braine-L’alleud.BRUNO FAHY/BELGA MAG/AFP via Getty Images
“By investing in Georgia, where our U.S. headquarters have been based for more than three decades, we are strengthening our biologics manufacturing capabilities, supporting our innovation pipeline, and creating high-quality jobs in a state that offers outstanding talent, a strong manufacturing tradition, and an ecosystem designed for sustainable, long-term success,” UCB CEO Jean-Christophe Tellier said.
UCB’s North American headquarters is located in Smyrna. Currently, it supports more than 400 jobs in the area.
Media Coverage
Georgia invests $1B to turn Route 316 into ‘workforce expressway’ between Atlanta and Athens
Originally posted in Atlanta Business Chronicle. A decade from now, a series of stop-and-start intersections along the state highway connecting Atlanta to Athens will be ditched in an effort to improve traffic flow and accommodate growth. Georgia’s Department of Transportation is investing approximately $1 billion into a long-term overhaul of state Route 316. The four-lane […]
Announcements
Rowen Foundation Announces Leadership Transition
The Rowen Foundation today announced that President and CEO Mason Ailstock will step down after accepting a new opportunity. The Rowen Board of Directors is conducting a national search for Rowen's next president and CEO with the Board anticipating new leadership later this fall.
Blog
Why Companies Are Choosing Georgia’s Largest Biotech Park
While Boston and San Francisco have long dominated the life sciences conversation, the Southeast is writing a new chapter, and Georgia is leading it. With 2,000 acres of preserved land for state-of-the-art facilities, labs, and collaboration spaces, Rowen is a compelling destination for biopharma and biotech industry investments that value collaborative learning, knowledge sharing, and transformative thinking.